Enanta stockholders approve 800k-share increase to 2019 equity plan; re-elect directors

ENANTA PHARMACEUTICALS INC

Stockholders approved amendment to 2019 Equity Incentive Plan, adding 800,000 shares (11,435,985 for, 4,085,303 against).
Mark G. Foletta and Lesley Russell re-elected as Class III directors until 2028 annual meeting.
Advisory vote on executive compensation passed (14,516,861 for, 1,039,888 against); frequency set to annual.
PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2025 (17,740,127 for, 72,357 against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.